EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential

Katharina Fleig, Leoni Haslinger, Christine Dawczynski, Iris-Tatjana Kolassa

Frontiers in Nutrition · 02.04.2026 · 13

DOI: 10.3389/fnut.2026.1748196 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 02.04.2026. Verfasst von Katharina Fleig und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nutritional psychiatry is an emerging field. Micro- and macro-nutrients play a role in energy metabolism and the regulation of inflammation; particularly, an insufficient dietary intake of omega-3 fatty acids and an imbalanced intake of omega-6/omega-3 fatty acids, with a shift toward increased inflammation, are of relevance for the pathophysiology of mental disorders. This review summarizes evidence on the role of omega-3 fatty acids in the pathophysiology of mental disorders (schizophrenia, affective and anxiety disorders, post-traumatic stress disorder, and eating disorders), neurodevelopmental disorders (attention-deficit/hyperactivity disorder and autism spectrum disorder) and neurodegenerative disorders (Alzheimer's disease) and explores potential treatment implications. In addition, the underlying neurobiological mechanisms through which omega-3 fatty acids might exert a protective effect are also discussed. Despite methodological variability and heterogeneous results, an increasing body of evidence suggests that omega-3 deficiency and altered fatty acid profiles are modifiable risk factors and potential biomarkers for mental disorders. The integration of omega-3 supplementation as an adjuvant to state-of-the-art therapy offers the potential for a low-risk intervention with meaningful clinical outcomes. However, clinical monitoring is recommended to avoid adverse effects and to adjust the dosage according to individual and disease-specific factors.

Schlagwörter

Stichwörter der Autor:innen

docosahexaenoic acideicosapentaenoic acidfatty acid profilemental disordersnutritional psychiatryomega-3 fatty acidsomega-6/omega-3 ratio

Autor:innen und Institutionen

  • Department of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany.
  • Department of Clinical & Biological Psychology, Faculty of Engineering, Computer Science and Psychology, Ulm University, Ulm, Germany.
  • German Center for Mental Health (DZPG), Partner Site Mannheim - Heidelberg - Ulm, Ulm, Germany.
  • German Center for Child & Adolescent Health (DZKJ), Partner Site Ulm, Ulm, Germany.
  • Institute of Nutritional Sciences, Friedrich Schiller University Jena, Jena, Germany.

Zitieren

APA

Fleig, K., Haslinger, L., Dawczynski, C., & Kolassa, I. T. (2026). Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1748196

Vancouver

Fleig K, Haslinger L, Dawczynski C, Kolassa IT. Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1748196

BibTeX
@article{Fleig2026,
  author = {Fleig, Katharina and Haslinger, Leoni and Dawczynski, Christine and Kolassa, Iris-Tatjana},
  title = {Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential},
  journal = {Frontiers in Nutrition},
  year = {2026},
  volume = {13},
  doi = {10.3389/fnut.2026.1748196}
}
Kostenlos starten →